TFRC and neoplasm: In vivo, the depletion of EPCs with anti-CD71 antibody rescued the suppressed proliferation of virus-specific CD8+ T-cells, restoring anti-viral immunity in tumor-bearing mice while the transfer of CD45+ EPCs potentiated the suppression of immune response [41].